Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria De Carluccio

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Neuropharmacology|February 24, 2025
Synaptic Interactions Between Serotonergic and Dopaminergic Systems in Parkinson's DiseaseGioia Marino, Federica Campanelli, Giuseppina Natale, et al.
NPJ Parkinson'S Disease|June 1, 2026
Dopamine-endocannabinoid crosstalk drives exercise-induced bidirectional plasticity in Parkinson's diseaseFederica Campanelli, Gioia Marino, Giuseppina Natale, et al.
NPJ Parkinson'S Disease|December 8, 2025
Backtracking α-synuclein pathology: social deficits precede motor symptoms in Parkinson's diseaseGioia Marino, Federica Campanelli, Giuseppina Natale, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 13, 2023
Astrocyte Responses Influence Local Effects of Whole-Brain Magnetic Stimulation in Parkinsonian RatsGiuseppina Natale, Micol Colella, Maria De Carluccio, et al.
International Journal of Molecular Sciences|July 12, 2025
Effect on Different Glial Cell Types of S100B Modulation in Multiple Sclerosis Experimental ModelsMaria De Carluccio, Gabriele Di Sante, Maria Elisabetta Clementi, et al.
International Journal of Molecular Sciences|December 24, 2021
S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune EncephalomyelitisChiara Camponeschi, Maria De Carluccio, Susanna Amadio, et al.
NPJ Parkinson'S Disease|July 29, 2025
Oligomeric alpha-synuclein causes early synaptic dysfunction of the corticostriatal pathway associated with non-motor symptomsLaura Bellingacci, Miriam Sciaccaluga, Alfredo Megaro, et al.
Science Advances|July 14, 2023
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson's disease restoring striatal synaptic plasticityGioia Marino, Federica Campanelli, Giuseppina Natale, et al.
NPJ Parkinson'S Disease|November 30, 2024
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson's DiseaseFederica Servillo, Maria De Carluccio, Giulia Di Lazzaro, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Neuropharmacology|February 24, 2025
Synaptic Interactions Between Serotonergic and Dopaminergic Systems in Parkinson's DiseaseGioia Marino, Federica Campanelli, Giuseppina Natale, et al.
NPJ Parkinson'S Disease|June 1, 2026
Dopamine-endocannabinoid crosstalk drives exercise-induced bidirectional plasticity in Parkinson's diseaseFederica Campanelli, Gioia Marino, Giuseppina Natale, et al.
NPJ Parkinson'S Disease|December 8, 2025
Backtracking α-synuclein pathology: social deficits precede motor symptoms in Parkinson's diseaseGioia Marino, Federica Campanelli, Giuseppina Natale, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 13, 2023
Astrocyte Responses Influence Local Effects of Whole-Brain Magnetic Stimulation in Parkinsonian RatsGiuseppina Natale, Micol Colella, Maria De Carluccio, et al.
International Journal of Molecular Sciences|July 12, 2025
Effect on Different Glial Cell Types of S100B Modulation in Multiple Sclerosis Experimental ModelsMaria De Carluccio, Gabriele Di Sante, Maria Elisabetta Clementi, et al.
International Journal of Molecular Sciences|December 24, 2021
S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune EncephalomyelitisChiara Camponeschi, Maria De Carluccio, Susanna Amadio, et al.
NPJ Parkinson'S Disease|July 29, 2025
Oligomeric alpha-synuclein causes early synaptic dysfunction of the corticostriatal pathway associated with non-motor symptomsLaura Bellingacci, Miriam Sciaccaluga, Alfredo Megaro, et al.
Science Advances|July 14, 2023
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson's disease restoring striatal synaptic plasticityGioia Marino, Federica Campanelli, Giuseppina Natale, et al.
NPJ Parkinson'S Disease|November 30, 2024
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson's DiseaseFederica Servillo, Maria De Carluccio, Giulia Di Lazzaro, et al.
Pageof 1